SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-065595
Filing Date
2023-08-10
Accepted
2023-08-10 16:06:15
Documents
90
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0623_immucell.htm   iXBRL 10-Q 1129320
2 AMENDMENT TO RIGHTS AGREEMENT BY AND BETWEEN IMMUCELL CORPORATION AND EQUINITI T f10q0623ex4-1_immucell.htm EX-4.1 10351
3 CERTIFICATION f10q0623ex31_immucell.htm EX-31 9816
4 CERTIFICATION f10q0623ex32_immucell.htm EX-32 4772
  Complete submission text file 0001213900-23-065595.txt   6912183

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE iccc-20230630.xsd EX-101.SCH 78660
6 XBRL CALCULATION FILE iccc-20230630_cal.xml EX-101.CAL 35570
7 XBRL DEFINITION FILE iccc-20230630_def.xml EX-101.DEF 297382
8 XBRL LABEL FILE iccc-20230630_lab.xml EX-101.LAB 609163
9 XBRL PRESENTATION FILE iccc-20230630_pre.xml EX-101.PRE 317216
84 EXTRACTED XBRL INSTANCE DOCUMENT f10q0623_immucell_htm.xml XML 1064655
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 231159310
SIC: 2835 In Vitro & In Vivo Diagnostic Substances